M&A Deal Summary

Monsanto Acquires WestBred

On July 14, 2009, Monsanto acquired food company WestBred for 45M USD

Acquisition Highlights
  • This is Monsanto’s 2nd transaction in the Food sector.
  • This is Monsanto’s 5th largest (disclosed) transaction.
  • This is Monsanto’s 5th transaction in the United States.
  • This is Monsanto’s 1st transaction in Montana.

M&A Deal Summary
Date 2009-07-14
Target WestBred
Sector Food
Buyer(s) Monsanto
Deal Type Add-on Acquisition
Deal Value 45M USD
Advisor(s) William & Henry Associates (Financial)

Target

WestBred

Bozeman, Montana, United States
WestBred, LLC operates as a research and development company for cereal grains in North America.

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Monsanto

St. Louis, Missouri, United States
Category Company
Founded 2000
Sector Agriculture
Employees22,500
Revenue 15.0B USD (2015)
DESCRIPTION
Entrance to Monsanto's corporate headquarters in St. Louis, Missouri.
Entrance to Monsanto's corporate headquarters in St. Louis, Missouri.

Monsanto Co. is a chemical and agricultural biotechnology company offering farmers a wide range of corn, soybean, cotton, wheat, canola, sorghum and sugar cane seeds. Monsanto was formed in 2000 and is based in St. Louis, Missouri.

DEAL STATS #
Overall 7 of 11
Sector (Food) 2 of 2
Type (Add-on Acquisition) 7 of 10
State (Montana) 1 of 3
Country (United States) 5 of 9
Year (2009) 1 of 1
Size (of disclosed) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-08-20 Posilac

United States

Posilac (rbST) is approved by numerous regulatory authorities worldwide to help dairy farmers improve milk productivity. BST (bovine somatotropin) is a natural protein produced in all cattle, helping adult cows produce milk. Milk from cows receiving Posilac is unchanged from milk from cows not receiving this supplement.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-22 Divergence

St. Louis, Montana, United States

Divergence, Inc., a provider in the application of genomics and informatics to agriculture and infectious disease, discovers and develops products for the safe and effective control of parasites. The company's focus is on parasitic nematodes, devastating unseen pests that cause billions of dollars in crop loss annually and widespread disease in humans and animals.

Buy -
Mergr

Product

Company

Legal